Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

ARTAÇ M., Bozcuk H., Kiyici A., Eren O. O., Boruban M. C., Ozdogan M.

BREAST CANCER, vol.20, no.2, pp.174-180, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 2
  • Publication Date: 2013
  • Doi Number: 10.1007/s12282-011-0322-1
  • Journal Name: BREAST CANCER
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.174-180
  • Keywords: Metastatic breast cancer, Leptin, Waist-to-hip ratio, Weight, Aromatase inhibitors, Hormonal therapy, BODY-MASS-INDEX, PLASMA LEPTIN, FACTOR-ALPHA, OBESITY, WOMEN, MECHANISMS, ADIPONECTIN, METABOLISM, EXPRESSION, TAMOXIFEN
  • Akdeniz University Affiliated: Yes

Abstract

Our objective was to determine whether serum leptin levels and obesity-related factors could affect outcome for metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs).